Skip to Content

Switch language English
- Switch language
- Deutsch
- English
- Español
- Français
- Italiano
- Português do Brasil
- 中文
Login

ScholarsArchive@OSU

Home
About
Help
Contact

Search ScholarsArchive@OSU

Advanced Search

Search Constraints

Start Over

Filtering by: Creator Hartung, Daniel M. Remove constraint Creator: Hartung, Daniel M. Creator Bourdette, Dennis N. Remove constraint Creator: Bourdette, Dennis N.

1 - 5 of 5

Relevance
Title [A-Z]
Title [Z-A]
Date Created ▼
Date Created ▲
Date Uploaded ▼
Date Uploaded ▲

Number of results to display per page

10 per page
20 per page
50 per page
100 per page

View results as:

List Gallery Masonry

Search Results

HartungDanielPharmacyCostMulitpleSclerosis(Podcast).mp3

Creator:

Hartung, Daniel M., Bourdette, Dennis N., Ahmed, Sharia M., and Whitham, Ruth H.

Abstract:

Objective: To examine the pricing trajectories in the United States of disease-modifying therapies (DMT) for multiple sclerosis (MS) over the last 20 years and assess the influences on rising prices. Methods: We estimated the trend in annual drug costs for 9 DMTs using published drug pricing data from 1993 to...
HartungDanielPharmacyCostMulitpleSclerosisSupplementaryAppendix.pdf

Creator:

Hartung, Daniel M., Bourdette, Dennis N., Ahmed, Sharia M., and Whitham, Ruth H.

Abstract:

Objective: To examine the pricing trajectories in the United States of disease-modifying therapies (DMT) for multiple sclerosis (MS) over the last 20 years and assess the influences on rising prices. Methods: We estimated the trend in annual drug costs for 9 DMTs using published drug pricing data from 1993 to...
HartungDanielPharmacyCostMulitpleSclerosis(Correction).pdf

Creator:

Hartung, Daniel M., Bourdette, Dennis N., Ahmed, Sharia M., and Whitham, Ruth H.

Abstract:

Objective: To examine the pricing trajectories in the United States of disease-modifying therapies (DMT) for multiple sclerosis (MS) over the last 20 years and assess the influences on rising prices. Methods: We estimated the trend in annual drug costs for 9 DMTs using published drug pricing data from 1993 to...
HartungDanielPharmacyCostMulitpleSclerosis.pdf

Creator:

Hartung, Daniel M., Bourdette, Dennis N., Ahmed, Sharia M., and Whitham, Ruth H.

Abstract:

Objective: To examine the pricing trajectories in the United States of disease-modifying therapies (DMT) for multiple sclerosis (MS) over the last 20 years and assess the influences on rising prices. Methods: We estimated the trend in annual drug costs for 9 DMTs using published drug pricing data from 1993 to...
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?

Creator:

Hartung, Daniel M., Bourdette, Dennis N., Ahmed, Sharia M., and Whitham, Ruth H.

Abstract:

Objective: To examine the pricing trajectories in the United States of disease-modifying therapies (DMT) for multiple sclerosis (MS) over the last 20 years and assess the influences on rising prices. Methods: We estimated the trend in annual drug costs for 9 DMTs using published drug pricing data from 1993 to...

Resource Type:

Article

Limit your search

Creator

Ahmed, Sharia M.5
Bourdette, Dennis N.5
Hartung, Daniel M.[remove]5
Whitham, Ruth H.5

Date

20151

Decade

2010-20191

Language

English [eng]1

Peer Reviewed

Yes1

Resource Type

Article1

Rights Statement

In Copyright5

Scholars Archive is a service of Oregon State University Libraries & Press

121 The Valley Library
Corvallis, OR 97331-4501

Contact Us
Services for Persons with Disabilities

Powered by Hyrax 3.6.0

Copyright © 2018 Oregon State University
Licensed under the Apache License, Version 2.0

Core Trust application (pdf)